These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

751 related articles for article (PubMed ID: 9151539)

  • 1. An overview of Food and Drug Administration regulation of drugs, biologics, and devices to be used for management of periodontal diseases.
    Tylenda CA; Weintraub M
    Ann Periodontol; 1997 Mar; 2(1):11-7. PubMed ID: 9151539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory issues relating to therapies for periodontal regeneration.
    Singleton DG; Torres-Cabassa A
    Ann Periodontol; 1997 Mar; 2(1):223-8. PubMed ID: 9151556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory issues unique to clinical trials on periodontal diagnostic methods and devices.
    Gutman SI; Tylenda CA
    Ann Periodontol; 1997 Mar; 2(1):108-12. PubMed ID: 9151547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical devices: US medical device regulation.
    Jarow JP; Baxley JH
    Urol Oncol; 2015 Mar; 33(3):128-32. PubMed ID: 25458071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New orthopedic devices and the FDA.
    Sheth U; Nguyen NA; Gaines S; Bhandari M; Mehlman CT; Klein G
    J Long Term Eff Med Implants; 2009; 19(3):173-84. PubMed ID: 20939777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supplemental applications proposing labeling changes for approved drugs, biologics, and medical devices. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2008 Aug; 73(164):49603-10. PubMed ID: 18958946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory aspects of invasive glucose measurements.
    Gutman S; Bernhardt P; Pinkos A; Moxey-Mims M; Knott T; Cooper J
    Diabetes Technol Ther; 2002; 4(6):775-7. PubMed ID: 12685800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of Clinical Studies Conducted Over the Total Product Life Cycle of High-Risk Therapeutic Medical Devices Receiving FDA Premarket Approval in 2010 and 2011.
    Rathi VK; Krumholz HM; Masoudi FA; Ross JS
    JAMA; 2015 Aug; 314(6):604-12. PubMed ID: 26262798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical devices; investigational device exemptions--FDA. Final rule.
    Fed Regist; 1998 Nov; 63(225):64617-26. PubMed ID: 10338870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical devices; investigational device exemptions--FDA. Proposed rule.
    Fed Regist; 1998 Jul; 63(135):38131-8. PubMed ID: 10181246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory issues for evaluation of therapies to prevent or arrest disease progression.
    Hyman FN; Welch ME; Cheever JR
    Ann Periodontol; 1997 Mar; 2(1):166-79. PubMed ID: 9151552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical devices; exemptions from premarket notification and reserved devices; class I--FDA. Notice.
    Fed Regist; 1998 Feb; 63(21):5387-93. PubMed ID: 10177333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An overview of FDA medical device regulation as it relates to deep brain stimulation devices.
    Peña C; Bowsher K; Costello A; De Luca R; Doll S; Li K; Schroeder M; Stevens T
    IEEE Trans Neural Syst Rehabil Eng; 2007 Sep; 15(3):421-4. PubMed ID: 17894274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical devices; exemption from premarket notification and reserved devices; class I. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Jan; 65(10):2296-323. PubMed ID: 11010655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical devices containing materials derived from animal sources (except for in vitro diagnostic devices), guidance for FDA reviewers and industry; availability--FDA. Notice.
    Fed Regist; 1998 Nov; 63(215):60009-10. PubMed ID: 10187389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Food and Drug Administration's regulation of dental products.
    Pinco RG; Rubin PD
    J Clin Dent; 1995; 6(3):165-9. PubMed ID: 8615957
    [No Abstract]   [Full Text] [Related]  

  • 17. Medical devices; exemptions from premarket notification; class II devices--FDA, Final rule.
    Fed Regist; 1998 Nov; 63(212):59222-31. PubMed ID: 10187384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination products regulation at the FDA.
    Lauritsen KJ; Nguyen T
    Clin Pharmacol Ther; 2009 May; 85(5):468-70. PubMed ID: 19381151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How do Orthopaedic Devices Change After Their Initial FDA Premarket Approval?
    Samuel AM; Rathi VK; Grauer JN; Ross JS
    Clin Orthop Relat Res; 2016 Apr; 474(4):1053-68. PubMed ID: 26584802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Food and Drug Administration and the regulation of clinical trials for endosseous implants.
    Scott PD; Runner S
    Ann Periodontol; 1997 Mar; 2(1):284-90. PubMed ID: 9151561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.